Solutions et réactifs de la Pharmacopée européenne (Ph. Eur.)

Les solutions et réactifs de la Pharmacopée Européenne (Ph. Eur.) garantissent que les produits pharmaceutiques répondent aux normes de qualité élevées fixées par l'Union Européenne. Ces solutions sont essentielles pour tester la pureté, la puissance et la qualité des médicaments. Chez CymitQuimica, nous offrons une large gamme de solutions et réactifs conformes à la Ph. Eur., soutenant la recherche pharmaceutique et les processus de contrôle qualité.

Trier par

Tri par prix ascendant

Tri par prix descendant

Puretés inférieures en premier

Puretés supérieures en premier

Livraison estimée la plus rapide en premier

20
- 50
- 100
- 200

produits par page. 9163 produits dans cette catégorie.

Informations sur le produit	Degré de pureté	Gamme de prix	Livraison estimée
Reagecon Sodium Edetate 0.1M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2) REF : 07-3005900	- - -	55,00 €	mer 09 Oct 24
Reagecon Simulated Intestinal Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate REF : 07-DBC13-250	- - -	558,00 €	mer 09 Oct 24
Reagecon Ammonium Molybdate R2 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1005703	- - -	106,00 €	mer 09 Oct 24
Reagecon Y3 Yellow Colour Reference Solution according to European Pharmacopoeia (EP) REF : 07-EPY301	- - -	110,00 €	mer 09 Oct 24
Reagecon Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate REF : 07-DBC10-250	- - -	475,00 €	mer 09 Oct 24
Reagecon Concentrate to make Chloride (Cl) 8ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test REF : 07-5000900C	- - -	161,00 €	mer 09 Oct 24
IC Cation Standard Sodium 2000ppm in H2O REF : 07-ICCR04	- - -	88,00 €	mer 09 Oct 24
Reagecon Hydrochloric Acid Dilute R1 according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1043504	- - -	311,00 €	mer 09 Oct 24
Reagecon Phosphate Buffer Solution R1 pH 6.80 according to European Pharmacopoeia (EP) Chapter 4 (4.1.3) REF : 07-4003400-R1	- - -	86,00 €	mer 09 Oct 24
Reagecon Potassium Chromate Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1069201CAS : 7789-00-6	- - -	163,00 €	mer 09 Oct 24
Reagecon Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate REF : 07-DBC06-230	- - -	396,00 €	mer 09 Oct 24
Reagecon Silver Nitrate R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1078301	- - -	À demander	mer 09 Oct 24
Reagecon Potassium Bromate 0.033M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2) REF : 07-3004200	- - -	142,00 €	mer 09 Oct 24
Reagecon Potassium Iodide Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1070502	- - -	163,00 €	mer 09 Oct 24
Reagecon Acetic Acid Dilute (12%) according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1000402	- - -	57,00 €	mer 09 Oct 24
Reagecon Lead Acetate Cotton according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1048101	- - -	163,00 €	mer 09 Oct 24
Reagecon Acetic Anhydride R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1000501	- - -	455,00 €	mer 09 Oct 24
Reagecon Zinc Chloride 0.05M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2) REF : 07-3008500	- - -	314,00 €	mer 09 Oct 24
Reagecon Potassium Chloride 0.1M Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1069101	- - -	88,00 €	mer 09 Oct 24
Reagecon Diphenylamine R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1) REF : 07-1032102	- - -	114,00 €	mer 09 Oct 24

Solutions et réactifs de la Pharmacopée européenne (Ph. Eur.)

Reagecon Sodium Edetate 0.1M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2)

Ref: 07-3005900

Reagecon Simulated Intestinal Fluid without Enzyme Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate

Ref: 07-DBC13-250

Reagecon Ammonium Molybdate R2 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1005703

Reagecon Y3 Yellow Colour Reference Solution according to European Pharmacopoeia (EP)

Ref: 07-EPY301

Reagecon Hydrochloric Acid 0.01N Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate

Ref: 07-DBC10-250

Reagecon Concentrate to make Chloride (Cl) 8ppm Standard Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.2) Limit Test

Ref: 07-5000900C

IC Cation Standard Sodium 2000ppm in H2O

Ref: 07-ICCR04

Reagecon Hydrochloric Acid Dilute R1 according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1043504

Reagecon Phosphate Buffer Solution R1 pH 6.80 according to European Pharmacopoeia (EP) Chapter 4 (4.1.3)

Ref: 07-4003400-R1

Reagecon Potassium Chromate Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1069201

Reagecon Acetate Buffer pH 4.5 Dissolution Media in accordance to United States (USP) and European Pharmacopoeias (EP) Concentrate

Ref: 07-DBC06-230

Reagecon Silver Nitrate R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1078301

Reagecon Potassium Bromate 0.033M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2)

Ref: 07-3004200

Reagecon Potassium Iodide Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1070502

Reagecon Acetic Acid Dilute (12%) according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1000402

Reagecon Lead Acetate Cotton according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1048101

Reagecon Acetic Anhydride R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1000501

Reagecon Zinc Chloride 0.05M according to European Pharmacopoeia (EP) Chapter 4 (4.2.2)

Ref: 07-3008500

Reagecon Potassium Chloride 0.1M Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1069101

Reagecon Diphenylamine R1 Solution according to European Pharmacopoeia (EP) Chapter 4 (4.1.1)

Ref: 07-1032102